RxSight, Inc.
RXST
$25.95
$0.732.90%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.88% | 1.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.88% | 1.22% | |||
| Cost of Revenue | 13.20% | -5.10% | |||
| Gross Profit | 14.15% | 4.00% | |||
| SG&A Expenses | 10.10% | 5.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.66% | 3.05% | |||
| Operating Income | 6.48% | -10.72% | |||
| Income Before Tax | 6.31% | -4.32% | |||
| Income Tax Expenses | -7.69% | -18.75% | |||
| Earnings from Continuing Operations | 6.31% | -4.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.31% | -4.26% | |||
| EBIT | 6.48% | -10.72% | |||
| EBITDA | -0.25% | -7.61% | |||
| EPS Basic | 7.66% | -0.76% | |||
| Normalized Basic EPS | 7.65% | -0.91% | |||
| EPS Diluted | 7.66% | -0.76% | |||
| Normalized Diluted EPS | 7.65% | -0.91% | |||
| Average Basic Shares Outstanding | 1.43% | 3.47% | |||
| Average Diluted Shares Outstanding | 1.43% | 3.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
